A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
Health Ronovo Surgical raises $67M, led by J&J venture armHealthradar8. September 2025 Dive Brief: China’s Ronovo Surgical has closed a $67 million Series D financing round led by JJDC, Johnson & Johnson’s…
Health Caduceus Capital Partners Forms Digital Health Consulting Arm Caduceus ADVISORYHealthradar18. Juli 2025 Adam Bauer Named CEO of New Business NASHVILLE, Tenn.–(BUSINESS WIRE)–#digitalhealth—Caduceus Capital Partners (Caduceus) today announced the formation of Caduceus ADVISORY,…
